BGI Genomics Co., Ltd. (SZSE:300676) agreed to acquire the remaining 1% stake in Beijing BGI Medical Laboratory Co., Ltd. from Beijing BGI Research Centre Co., Ltd. for CNY 2.37 million on April 22, 2021. B. BGI Genomics Co., Ltd shall pay the Beijing Research Center in one lump sum by bank transfer in accordance with the currency and amount specified in the above clauses within 90 days from the effective date of this agreement. The funds for this transaction come from BGI Genomics Co., Ltd. own funds. Beijing BGI Medical Laboratory Co., Ltd. reported total assets of CNY 47.5053 million and net assets of CNY -5.59 million for March 31, 2021. The board of directors of BGI Genomics Co., Ltd. approved the transaction in the 30th meeting of the second board of directors held on April 22, 2021.